Compare Okta, Inc. (OKTA) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Okta, Inc. vs Recursion Pharmaceuticals Inc — how do they compare? Okta, Inc. trades at $136.54 (market cap $24.63B), while Recursion Pharmaceuticals Inc trades at $2.99 (market cap $1.63B). The key difference: Okta, Inc. is far larger — about 15.1× Recursion Pharmaceuticals Inc's market cap, and Okta, Inc. is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| OKTA | RXRX | |
|---|---|---|
Market Cap | $24.63B | $1.63B |
Sector | Technology | Health |
52-Week High | $154.62 | $6.79 |
52-Week Low | $62.93 | $2.84 |
Enterprise Value | $22.45B | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
